Vivid Dx: Funding, Investors & Team (Sep 2026)
Vivid Dx is a diagnostics company that focuses on pathogen detection and antimicrobial resistance testing services.
Vivid Dx has raised $15.0M across 1 funding round on record, the most recent a Seed of $15.0M announced in Jul 2026.
That round is above the $4.0M median round size for United Kingdom companies tracked on FundedIQ over the last two years.
Vivid Dx Company Profile and Key Stats
Latest funding round on record: Jul 2026.
Vivid Dx Funding Rounds
Vivid Dx Investors
Vivid Dx Founders and Leadership Team
Contact details for the Vivid Dx team: 1 of 1 has an email address on file, 1 has a LinkedIn profile.
Start 14-day free trial →Vivid Dx Funding in Context
Vivid Dx's latest round of $15.0M is above the median round in United Kingdom. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Vivid Dx in Bioinformatics and Oxford
Companies Similar to Vivid Dx
SCI Semiconductor is developing and commercialising next generation, cyber-secure processor devices.
HelmGuard develops an AI-driven trust infrastructure platform for security, compliance, and third-party risk…
Sensors and AI models to digitize our sense of smell for better health.
Real growth. Realized. Digital Experience Platform for Financial Services.
KVector creates communication and sensing solutions with high gain and efficiency from X-band to…
ViaNautis, previously known as SomaServe, was established in 2018 as a separate entity from UCL under the…
Universal Quantum is building quantum computers to tackle real-world problems that would take today’s fastest…
Veridue uses AI to automate M&A due diligence and project finance for renewable energy.
SplitPay is a mobile app that offers credit with a buy now, pay later option.
Land Digital is a tech, web design, web creation, content marketing, digital marketing, SEO, and mobile…
JAB is a premium athletic ecosystem offering luxury boxing sessions, strength training, and dedicated…
Feisty produces plant-based protein sodas made with pea protein, real fruit juice, and low-calorie,…
Vivid Dx Funding FAQs
What does Vivid Dx do?
Vivid Dx is a diagnostics company that focuses on pathogen detection and antimicrobial resistance testing services.
How much funding has Vivid Dx raised?
Vivid Dx has raised $15.0M across 1 round on record. The most recent is a Seed of $15.0M announced in Jul 2026.
When did Vivid Dx last raise funding?
Vivid Dx's most recent funding round on record is a Seed of $15.0M, announced in Jul 2026.
Who has invested in Vivid Dx?
Investors on record for Vivid Dx include Oxford Science Enterprises, Jameel Investment Management Company, UK Research and Innovation, Cedars-Sinai Intellectual Property Company.
Where is Vivid Dx headquartered?
Vivid Dx is based in Oxford, United Kingdom.
How many employees does Vivid Dx have?
Vivid Dx is in the 11-50 employee band.
About FundedIQ's Vivid Dx Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Vivid Dx is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.